HepaLife Technologies Inc. (OTC:HPLF) is now Alliqua Inc.
HepaLife Technologies Inc.
HepaLife Technologies Inc. (OTC:HPLF) has acquired the maker of hydrogels used for transdermal drug delivery in an all-stock deal valued at about $16 million.
In addition to the May 11 all-stock deal for privately held AquaMed Technologies Inc. of Langhorne, Pa., HepaLife also said that Amit Dang had quit as interim president and CEO at the company and would be replaced by Richard Rosenblum, a principal and investment manager at Harborview Advisors in Ponte Vedra Beach, Fla.
Dang, a managing director at Infinitus Ventures, joined HepaLife on Oct. 13, 2009 after former CEO Frank Menzler resigned to become a special technical advisor with the company.